WHO ICTRP trial
Prospective study to assess the emergence of drug resistance to oseltamivir…
EUCTR2005-005239-80-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-005239-80-GB |
|---|---|
| Public title | Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance study |
| Scientific title | Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance study |
| Primary sponsor | University Hospitals Leicester, Leicester General Hospital |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | Influenza A |
| Interventions | Trade Name: tamiflu suspension Product Name: Tamiflu Pharmaceutical Form: Oral suspension |
| Registration date | Feb 12, 2005 |
| Target size | 100 |
| Secondary IDs | 10007 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: